Бізнес · 05.01.19991 хв читання
Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics; Availability; Reopening of Comment Period
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA) is reopening until February 12, 1999, the comment period for the draft guidance for industry entitled ``Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics'' that appeared in the Federal Register of October 14, 1998 (63 FR 55067). FDA is taking this action in response to a request for an extension.